Recognition Referral: Best Practices for Managing Patients w -

Overview
Patients with advanced dry age-related macular degeneration can present with geographic atrophy (GA), a disease that is progressive and increases with age. Although there is no treatment approved by the FDA that halts or reverses GA, a number of drugs in the pipeline are designed to address GA progression, hoping to succeed where previous drug candidates failed. This series of regional, interactive, virtual symposia are designed to educate eye care providers on the importance of diagnosis and potential treatment options so they may plan accordingly for the best possible care of patients with GA.
This educational activity is designed for optometrists and general ophthalmologists.
This activity is supported by an unrestricted educational grant from Apellis Pharmaceuticals.
Learning Objectives
Upon completion of this activity, the participant should be able to:
- Discuss the prevalence of age-related macular degeneration
- Articulate the burden of illness linked to geographic atrophy (GA)
- Understand the pathogenesis of GA
- Describe disease detection and factors influencing progression
- Review the therapeutic interventions that have been explored as well as those in the pipeline
Accreditation
Provided by Evolve Medical Education

Evolve Medical Education LLC (Evolve) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Evolve designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Evolve is an approved COPE Administrator. This activity, COPE Activity Number 121612, is accredited by COPE for continuing education for optometrists for 1.5 hours.
COPE Course ID: 72029-PS
COPE Activity ID: 121612
Participation Method
In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.
Faculty and Disclosures
David R. Lally, MD
Retina Research Institute at New England Retina Consultants
Assistant Professor
University of Massachusetts
Springfield, MA

DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.
The following faculty/staff members have the following financial relationships with commercial interests:
David R. Lally, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Annexon, Apellis Pharmaceuticals, and Iveric Bio. Grant/Research Support: Annexon, Apellis, Iveric Bio, and Stealth Biotherapeutics. Speaker’s Bureau: Apellis Pharmaceuticals, and Stealth Biotherapeutics.
The Evolve staff and planners have no financial relationships with commercial interests.
Nisha Mukherjee, MD, peer reviewer, has no financial relationships with commercial interests.
Disclaimer
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Apellis Pharmaceuticals.
System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
  Apple Safari for Mac OS and iOS
  Mozilla Firefox for Windows, Mac OS, iOS, and Android
  Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
Publication Dates
Release Date: 06/15/2021
Expiration Date: 06/19/2021

David R. Lally, MD

Guest

Recommended

Title

Share on ReachMD